We then prioritized candidates with unique locations or behaviors: candidate C2 overlaps SChLAP1, a known lncRNA indicator of aggressive prostate cancers [12]; C3 and C4 are located on the X chromosome, evoking the well-known link between X-chromosome variations and prostate cancer [29]; C5 was the only candidate to show significantly elevated expression in indolent cancers; and C6 appears to be an extension of SChLAP1. Here, SCHLAP1 is linked to cancer.